Jang Hyun Koh Selected Research

Jang Hyun Koh Research Topics

4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2014 - 04/2007
3	Type 2 Diabetes Mellitus (MODY) 01/2014 - 12/2008
2	Body Weight (Weight, Body) 05/2010 - 02/2009
2	Insulin Resistance 01/2009 - 12/2008
1	Osteoporosis 01/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Albuminuria 01/2014
1	Non-alcoholic Fatty Liver Disease 01/2009
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2009
1	Atherosclerosis 01/2009

4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 04/2007
3	Glucose (Dextrose)FDA LinkGeneric 01/2014 - 12/2008
2	CreatinineIBA 05/2010 - 02/2009
2	AlbuminsIBA 05/2010 - 02/2009
2	Proteins (Proteins, Gene)FDA Link 02/2009 - 01/2009
2	Insulin (Novolin)FDA Link 01/2009 - 12/2008
2	ThiazolidinedionesIBA 12/2008 - 04/2007
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2022
1	AntioxidantsIBA 01/2014
1	Taurine FDA Link 01/2014
1	fidarestatIBA 05/2010
1	Aldehyde Reductase (Aldose Reductase)IBA 05/2010
1	Blood Glucose (Blood Sugar)IBA 05/2010
1	acetovanillone (apocynin)IBA 02/2009
1	NADP (NADPH)IBA 02/2009
1	NADPH Oxidases (NAD(P)H oxidase)IBA 02/2009
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2009
1	C-Reactive ProteinIBA 01/2009
1	Fatty Acid-Binding ProteinsIBA 01/2009
1	AdiponectinIBA 01/2009
1	HDL CholesterolIBA 01/2009
1	Triglycerides (Triacylglycerol)IBA 01/2009
1	Pioglitazone (Actos)FDA Link 12/2008
1	Rosiglitazone (Avandia)FDA Link 12/2008
1	2,4-thiazolidinedione (thiazolidinedione)IBA 04/2007

1	Therapeutics 01/2022